Disclosures for "The Phase Four OCTAGON Study Investigating Oral Corticosteroid Tapering in Adult Patients With Generalized Myasthenia Gravis (gMG) Treated With Ravulizumab: Trial in Progress"
-
Dr. Yungher has received personal compensation for serving as an employee of Alexion AstraZeneca Rare Disease.
-
Dr. Weiskopf has received personal compensation for serving as an employee of Alexion AstraZeneca Rare Disease. Dr. Weiskopf has stock in Alexion Astrazeneca Rare Disease.
-
Rasha Aguzzi has received personal compensation for serving as an employee of Alexion Pharmaceutical. Rasha Aguzzi has stock in AstraZeneca.
-
Guido Sabatella has received personal compensation for serving as an employee of Alexion.